Lancet: Pandemic Containment Requires Increased Vaccine Production, Affordable Pricing & Global Allocation; WHO Calls For Tech Transfer To Scale Up Manufacturing 14/02/2021 Madeleine Hoecklin The contribution COVID-19 vaccines can make to beating the pandemic will depend on the extent to which they are produced at scale, priced affordably, and deployed globally, says the first peer reviewed study on equitable access to vaccines, published in The Lancet on Friday. The Lancet article comes in the wake of a joint appeal […] Continue reading -> South Africa’s Second COVID Wave Passes Despite Variant – AstraZeneca Vaccines For Health Workers’ Arrive But At Higher Price Than EU Paid 02/02/2021 Kerry Cullinan CAPE TOWN – Despite battling against a more infectious variant, South Africa seems to have ridden out its second and deadliest wave of COVID-19 infections. And with new case counts declining, the government relaxed its most recent set of lockdown restrictions on Tuesday – reopening beaches, and easing night-time curfews and a ban on alcohol […] Continue reading -> European Medicines Agency and Swissmedic Approve Pfizer’s COVID-19 Vaccine – Positioning Europe To Start Immunizations On Heels Of US, Canada, UK and Israel 21/12/2020 Elaine Ruth Fletcher The European Medicines Agency (EMA) announced on Monday that it would recommend conditional marketing authorization for the Pfizer/BioNTech COVID-19 vaccine – positioning Europe to finally begin rolling out vaccines across the continent – albeit after the United States, Canada, the United Kingdom and Israel have already moved into high gear vaccine campaigns. Mass vaccinations were […] Continue reading -> As Rich Countries Roll Out COVID-19 Vaccines – Will Developing Countries Miss Out? 09/12/2020 Elaine Ruth Fletcher While some of the world’s richest countries have now stockpiled more COVID vaccines than they have people to inject, the world’s 67 poorest countries may only be able to vaccinate 1 in 10 people against COVID-19 next year, unless urgent action is taken by governments and the pharmaceutical industry to make sure enough doses are […] Continue reading -> Pfizer COVID-19 Vaccine Makes It First To Finish Line; United Kingdom Authorizes Today & Rollout Begins Next Week 02/12/2020 Elaine Ruth Fletcher Pfizer’s COVID-19 vaccine, a cutting edge mRNA technology produced jointly with the German firm BioNTech, was authorized for use on Wednesday by the United Kingdom – making it the vaccine the first to be rolled out for commercial public use as early as next week. The vaccine was authorised Wednesday morning for emergency use by […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> How Can “Open Innovation” Support Research On Infectious Diseases? 18/11/2020 Geoffrey Kamadi Finding the right combination of open innovation – that is the free sharing of expertise, knowledge and data – and intellectual property (IP) that may drive private investments in expensive new technologies, can be a difficult balancing act to attain. But as the COVID-19 pandemic has underlined, it is more and more critical to etch […] Continue reading -> WHO Proposes Swiss-Based Global Repository For Sharing Biological Samples Related To Disease Outbreak Threats 13/11/2020 Menaka Rao & Elaine Ruth Fletcher BREAKING – World Health Organization Director-General, Dr Tedros Adhanom Ghebreyesus has proposed the creation of a Swiss-based global repository for sharing pathogen materials and clinical samples related to potential outbreak threats – allowing for the more rapid development of medical interventions. The COVID-19 pandemic has shown the urgent need for this kind of system, said […] Continue reading -> $US 300 Million In New COVID-19 Funding Initiatives Rushed Out By Gates, France & European Commission 12/11/2020 Elaine Ruth Fletcher A series of new COVID-19 drug and vaccine funding commitments worth just over US$300 million were announced on Thursday by the Gates Foundation, France and the European Commission – amidst a quickening pace of anticipation that at least one, if not two, COVID-19 vaccines may soon become available. Appearing at the Paris Peace Forum, Melinda […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
South Africa’s Second COVID Wave Passes Despite Variant – AstraZeneca Vaccines For Health Workers’ Arrive But At Higher Price Than EU Paid 02/02/2021 Kerry Cullinan CAPE TOWN – Despite battling against a more infectious variant, South Africa seems to have ridden out its second and deadliest wave of COVID-19 infections. And with new case counts declining, the government relaxed its most recent set of lockdown restrictions on Tuesday – reopening beaches, and easing night-time curfews and a ban on alcohol […] Continue reading -> European Medicines Agency and Swissmedic Approve Pfizer’s COVID-19 Vaccine – Positioning Europe To Start Immunizations On Heels Of US, Canada, UK and Israel 21/12/2020 Elaine Ruth Fletcher The European Medicines Agency (EMA) announced on Monday that it would recommend conditional marketing authorization for the Pfizer/BioNTech COVID-19 vaccine – positioning Europe to finally begin rolling out vaccines across the continent – albeit after the United States, Canada, the United Kingdom and Israel have already moved into high gear vaccine campaigns. Mass vaccinations were […] Continue reading -> As Rich Countries Roll Out COVID-19 Vaccines – Will Developing Countries Miss Out? 09/12/2020 Elaine Ruth Fletcher While some of the world’s richest countries have now stockpiled more COVID vaccines than they have people to inject, the world’s 67 poorest countries may only be able to vaccinate 1 in 10 people against COVID-19 next year, unless urgent action is taken by governments and the pharmaceutical industry to make sure enough doses are […] Continue reading -> Pfizer COVID-19 Vaccine Makes It First To Finish Line; United Kingdom Authorizes Today & Rollout Begins Next Week 02/12/2020 Elaine Ruth Fletcher Pfizer’s COVID-19 vaccine, a cutting edge mRNA technology produced jointly with the German firm BioNTech, was authorized for use on Wednesday by the United Kingdom – making it the vaccine the first to be rolled out for commercial public use as early as next week. The vaccine was authorised Wednesday morning for emergency use by […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> How Can “Open Innovation” Support Research On Infectious Diseases? 18/11/2020 Geoffrey Kamadi Finding the right combination of open innovation – that is the free sharing of expertise, knowledge and data – and intellectual property (IP) that may drive private investments in expensive new technologies, can be a difficult balancing act to attain. But as the COVID-19 pandemic has underlined, it is more and more critical to etch […] Continue reading -> WHO Proposes Swiss-Based Global Repository For Sharing Biological Samples Related To Disease Outbreak Threats 13/11/2020 Menaka Rao & Elaine Ruth Fletcher BREAKING – World Health Organization Director-General, Dr Tedros Adhanom Ghebreyesus has proposed the creation of a Swiss-based global repository for sharing pathogen materials and clinical samples related to potential outbreak threats – allowing for the more rapid development of medical interventions. The COVID-19 pandemic has shown the urgent need for this kind of system, said […] Continue reading -> $US 300 Million In New COVID-19 Funding Initiatives Rushed Out By Gates, France & European Commission 12/11/2020 Elaine Ruth Fletcher A series of new COVID-19 drug and vaccine funding commitments worth just over US$300 million were announced on Thursday by the Gates Foundation, France and the European Commission – amidst a quickening pace of anticipation that at least one, if not two, COVID-19 vaccines may soon become available. Appearing at the Paris Peace Forum, Melinda […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Medicines Agency and Swissmedic Approve Pfizer’s COVID-19 Vaccine – Positioning Europe To Start Immunizations On Heels Of US, Canada, UK and Israel 21/12/2020 Elaine Ruth Fletcher The European Medicines Agency (EMA) announced on Monday that it would recommend conditional marketing authorization for the Pfizer/BioNTech COVID-19 vaccine – positioning Europe to finally begin rolling out vaccines across the continent – albeit after the United States, Canada, the United Kingdom and Israel have already moved into high gear vaccine campaigns. Mass vaccinations were […] Continue reading -> As Rich Countries Roll Out COVID-19 Vaccines – Will Developing Countries Miss Out? 09/12/2020 Elaine Ruth Fletcher While some of the world’s richest countries have now stockpiled more COVID vaccines than they have people to inject, the world’s 67 poorest countries may only be able to vaccinate 1 in 10 people against COVID-19 next year, unless urgent action is taken by governments and the pharmaceutical industry to make sure enough doses are […] Continue reading -> Pfizer COVID-19 Vaccine Makes It First To Finish Line; United Kingdom Authorizes Today & Rollout Begins Next Week 02/12/2020 Elaine Ruth Fletcher Pfizer’s COVID-19 vaccine, a cutting edge mRNA technology produced jointly with the German firm BioNTech, was authorized for use on Wednesday by the United Kingdom – making it the vaccine the first to be rolled out for commercial public use as early as next week. The vaccine was authorised Wednesday morning for emergency use by […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> How Can “Open Innovation” Support Research On Infectious Diseases? 18/11/2020 Geoffrey Kamadi Finding the right combination of open innovation – that is the free sharing of expertise, knowledge and data – and intellectual property (IP) that may drive private investments in expensive new technologies, can be a difficult balancing act to attain. But as the COVID-19 pandemic has underlined, it is more and more critical to etch […] Continue reading -> WHO Proposes Swiss-Based Global Repository For Sharing Biological Samples Related To Disease Outbreak Threats 13/11/2020 Menaka Rao & Elaine Ruth Fletcher BREAKING – World Health Organization Director-General, Dr Tedros Adhanom Ghebreyesus has proposed the creation of a Swiss-based global repository for sharing pathogen materials and clinical samples related to potential outbreak threats – allowing for the more rapid development of medical interventions. The COVID-19 pandemic has shown the urgent need for this kind of system, said […] Continue reading -> $US 300 Million In New COVID-19 Funding Initiatives Rushed Out By Gates, France & European Commission 12/11/2020 Elaine Ruth Fletcher A series of new COVID-19 drug and vaccine funding commitments worth just over US$300 million were announced on Thursday by the Gates Foundation, France and the European Commission – amidst a quickening pace of anticipation that at least one, if not two, COVID-19 vaccines may soon become available. Appearing at the Paris Peace Forum, Melinda […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As Rich Countries Roll Out COVID-19 Vaccines – Will Developing Countries Miss Out? 09/12/2020 Elaine Ruth Fletcher While some of the world’s richest countries have now stockpiled more COVID vaccines than they have people to inject, the world’s 67 poorest countries may only be able to vaccinate 1 in 10 people against COVID-19 next year, unless urgent action is taken by governments and the pharmaceutical industry to make sure enough doses are […] Continue reading -> Pfizer COVID-19 Vaccine Makes It First To Finish Line; United Kingdom Authorizes Today & Rollout Begins Next Week 02/12/2020 Elaine Ruth Fletcher Pfizer’s COVID-19 vaccine, a cutting edge mRNA technology produced jointly with the German firm BioNTech, was authorized for use on Wednesday by the United Kingdom – making it the vaccine the first to be rolled out for commercial public use as early as next week. The vaccine was authorised Wednesday morning for emergency use by […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> How Can “Open Innovation” Support Research On Infectious Diseases? 18/11/2020 Geoffrey Kamadi Finding the right combination of open innovation – that is the free sharing of expertise, knowledge and data – and intellectual property (IP) that may drive private investments in expensive new technologies, can be a difficult balancing act to attain. But as the COVID-19 pandemic has underlined, it is more and more critical to etch […] Continue reading -> WHO Proposes Swiss-Based Global Repository For Sharing Biological Samples Related To Disease Outbreak Threats 13/11/2020 Menaka Rao & Elaine Ruth Fletcher BREAKING – World Health Organization Director-General, Dr Tedros Adhanom Ghebreyesus has proposed the creation of a Swiss-based global repository for sharing pathogen materials and clinical samples related to potential outbreak threats – allowing for the more rapid development of medical interventions. The COVID-19 pandemic has shown the urgent need for this kind of system, said […] Continue reading -> $US 300 Million In New COVID-19 Funding Initiatives Rushed Out By Gates, France & European Commission 12/11/2020 Elaine Ruth Fletcher A series of new COVID-19 drug and vaccine funding commitments worth just over US$300 million were announced on Thursday by the Gates Foundation, France and the European Commission – amidst a quickening pace of anticipation that at least one, if not two, COVID-19 vaccines may soon become available. Appearing at the Paris Peace Forum, Melinda […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pfizer COVID-19 Vaccine Makes It First To Finish Line; United Kingdom Authorizes Today & Rollout Begins Next Week 02/12/2020 Elaine Ruth Fletcher Pfizer’s COVID-19 vaccine, a cutting edge mRNA technology produced jointly with the German firm BioNTech, was authorized for use on Wednesday by the United Kingdom – making it the vaccine the first to be rolled out for commercial public use as early as next week. The vaccine was authorised Wednesday morning for emergency use by […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> How Can “Open Innovation” Support Research On Infectious Diseases? 18/11/2020 Geoffrey Kamadi Finding the right combination of open innovation – that is the free sharing of expertise, knowledge and data – and intellectual property (IP) that may drive private investments in expensive new technologies, can be a difficult balancing act to attain. But as the COVID-19 pandemic has underlined, it is more and more critical to etch […] Continue reading -> WHO Proposes Swiss-Based Global Repository For Sharing Biological Samples Related To Disease Outbreak Threats 13/11/2020 Menaka Rao & Elaine Ruth Fletcher BREAKING – World Health Organization Director-General, Dr Tedros Adhanom Ghebreyesus has proposed the creation of a Swiss-based global repository for sharing pathogen materials and clinical samples related to potential outbreak threats – allowing for the more rapid development of medical interventions. The COVID-19 pandemic has shown the urgent need for this kind of system, said […] Continue reading -> $US 300 Million In New COVID-19 Funding Initiatives Rushed Out By Gates, France & European Commission 12/11/2020 Elaine Ruth Fletcher A series of new COVID-19 drug and vaccine funding commitments worth just over US$300 million were announced on Thursday by the Gates Foundation, France and the European Commission – amidst a quickening pace of anticipation that at least one, if not two, COVID-19 vaccines may soon become available. Appearing at the Paris Peace Forum, Melinda […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> How Can “Open Innovation” Support Research On Infectious Diseases? 18/11/2020 Geoffrey Kamadi Finding the right combination of open innovation – that is the free sharing of expertise, knowledge and data – and intellectual property (IP) that may drive private investments in expensive new technologies, can be a difficult balancing act to attain. But as the COVID-19 pandemic has underlined, it is more and more critical to etch […] Continue reading -> WHO Proposes Swiss-Based Global Repository For Sharing Biological Samples Related To Disease Outbreak Threats 13/11/2020 Menaka Rao & Elaine Ruth Fletcher BREAKING – World Health Organization Director-General, Dr Tedros Adhanom Ghebreyesus has proposed the creation of a Swiss-based global repository for sharing pathogen materials and clinical samples related to potential outbreak threats – allowing for the more rapid development of medical interventions. The COVID-19 pandemic has shown the urgent need for this kind of system, said […] Continue reading -> $US 300 Million In New COVID-19 Funding Initiatives Rushed Out By Gates, France & European Commission 12/11/2020 Elaine Ruth Fletcher A series of new COVID-19 drug and vaccine funding commitments worth just over US$300 million were announced on Thursday by the Gates Foundation, France and the European Commission – amidst a quickening pace of anticipation that at least one, if not two, COVID-19 vaccines may soon become available. Appearing at the Paris Peace Forum, Melinda […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> How Can “Open Innovation” Support Research On Infectious Diseases? 18/11/2020 Geoffrey Kamadi Finding the right combination of open innovation – that is the free sharing of expertise, knowledge and data – and intellectual property (IP) that may drive private investments in expensive new technologies, can be a difficult balancing act to attain. But as the COVID-19 pandemic has underlined, it is more and more critical to etch […] Continue reading -> WHO Proposes Swiss-Based Global Repository For Sharing Biological Samples Related To Disease Outbreak Threats 13/11/2020 Menaka Rao & Elaine Ruth Fletcher BREAKING – World Health Organization Director-General, Dr Tedros Adhanom Ghebreyesus has proposed the creation of a Swiss-based global repository for sharing pathogen materials and clinical samples related to potential outbreak threats – allowing for the more rapid development of medical interventions. The COVID-19 pandemic has shown the urgent need for this kind of system, said […] Continue reading -> $US 300 Million In New COVID-19 Funding Initiatives Rushed Out By Gates, France & European Commission 12/11/2020 Elaine Ruth Fletcher A series of new COVID-19 drug and vaccine funding commitments worth just over US$300 million were announced on Thursday by the Gates Foundation, France and the European Commission – amidst a quickening pace of anticipation that at least one, if not two, COVID-19 vaccines may soon become available. Appearing at the Paris Peace Forum, Melinda […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
How Can “Open Innovation” Support Research On Infectious Diseases? 18/11/2020 Geoffrey Kamadi Finding the right combination of open innovation – that is the free sharing of expertise, knowledge and data – and intellectual property (IP) that may drive private investments in expensive new technologies, can be a difficult balancing act to attain. But as the COVID-19 pandemic has underlined, it is more and more critical to etch […] Continue reading -> WHO Proposes Swiss-Based Global Repository For Sharing Biological Samples Related To Disease Outbreak Threats 13/11/2020 Menaka Rao & Elaine Ruth Fletcher BREAKING – World Health Organization Director-General, Dr Tedros Adhanom Ghebreyesus has proposed the creation of a Swiss-based global repository for sharing pathogen materials and clinical samples related to potential outbreak threats – allowing for the more rapid development of medical interventions. The COVID-19 pandemic has shown the urgent need for this kind of system, said […] Continue reading -> $US 300 Million In New COVID-19 Funding Initiatives Rushed Out By Gates, France & European Commission 12/11/2020 Elaine Ruth Fletcher A series of new COVID-19 drug and vaccine funding commitments worth just over US$300 million were announced on Thursday by the Gates Foundation, France and the European Commission – amidst a quickening pace of anticipation that at least one, if not two, COVID-19 vaccines may soon become available. Appearing at the Paris Peace Forum, Melinda […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Proposes Swiss-Based Global Repository For Sharing Biological Samples Related To Disease Outbreak Threats 13/11/2020 Menaka Rao & Elaine Ruth Fletcher BREAKING – World Health Organization Director-General, Dr Tedros Adhanom Ghebreyesus has proposed the creation of a Swiss-based global repository for sharing pathogen materials and clinical samples related to potential outbreak threats – allowing for the more rapid development of medical interventions. The COVID-19 pandemic has shown the urgent need for this kind of system, said […] Continue reading -> $US 300 Million In New COVID-19 Funding Initiatives Rushed Out By Gates, France & European Commission 12/11/2020 Elaine Ruth Fletcher A series of new COVID-19 drug and vaccine funding commitments worth just over US$300 million were announced on Thursday by the Gates Foundation, France and the European Commission – amidst a quickening pace of anticipation that at least one, if not two, COVID-19 vaccines may soon become available. Appearing at the Paris Peace Forum, Melinda […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
$US 300 Million In New COVID-19 Funding Initiatives Rushed Out By Gates, France & European Commission 12/11/2020 Elaine Ruth Fletcher A series of new COVID-19 drug and vaccine funding commitments worth just over US$300 million were announced on Thursday by the Gates Foundation, France and the European Commission – amidst a quickening pace of anticipation that at least one, if not two, COVID-19 vaccines may soon become available. Appearing at the Paris Peace Forum, Melinda […] Continue reading -> Posts navigation Older postsNewer posts